Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
The percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation (product code QZI) is a Class 3 Cardiovascular device reviewed by the Cardiovascular panel, intended for the treatment of atrial fibrillation using irreversible electroporation energy to ablate cardiac tissue. As a Class 3 device, it requires PMA. No regulation number has been assigned. It is not an implant and is not life-sustaining.
Research product code QZI in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- QZI
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- CV
- Submission Type
- 2
Device Characteristics
Definition
For the treatment of atrial fibrillation.
FEI Numbers
This FDA classification entry is associated with 37 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 37 registration numbers. Click on an entry to view related FDA registrations.